Stock Watch: Is Johnson & Johnson Edging Away From Pharma?

A Mixed Bag In Pharma And Mixed Messaging In Oncology Irks Investors

 
• By Andy Smith
Stock Watch Image, Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

More from Stock Watch

More from Business